Liothyronine hydrochloride

1-( p -Tolylsulfonyl)pyrrole is a pyrrole derivative. Its Fourier-Transform-Infrared, Fourier-Transform-Raman and NMR spectra have been studied.

Application 1-Methyl-4-(2&#8242:-methylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride has been used to study its effect on core temperature in C57BL/6J mice. Biochem/physiol Actions

Product descriptionAcylation reaction of 4-pyridylacetonitrile hydrochloride has been reported.Product application4-Pyridylacetonitrile hydrochloride was used in preparation of (2Z)-3-(4-hydroxyphenyl)-4-pyridin-4-ylacrylonitrile.

4-(4-Methoxyphenyl)butyric acid on demethylation with pyridinium hydrochloride affords 4-hydroxyphenylbutyric acid, a key starting material for the synthesis of preclinical candidate LY518674.

Molecular Formula: C12H12N2O·HCl Molecular Weight: 236.7 MDL No.: MFCD03840152 Storage Temperature: Store at 0-8°C

4-Hydroxyantipyrine is formed during oxidative deamination of aminopyrine . It is a metabolite of antipyrine .

Reversibly inhibits dihyroorotate dehydrogenase, the rate-limiting step in the de novo synthesis of pyrimidines, preventing DNA synthesis of activated lymphocytes (IC₅₀s = 0.09, 3.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Fmoc-L-Tyr(2,6-Cl2-Bzl)-OH is an Fmoc protected tyrosine derivative that is potentially useful for proteomics studies and solid phase peptide synthesis techniques. Tyrosine is a very important amino acid - one of the few amino acids which is